COMPARATIVE-ANALYSIS OF ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITIES OF DIDEOXYNUCLEOSIDE ANALOGS IN RESTING AND ACTIVATED PERIPHERAL-BLOOD MONONUCLEAR-CELLS
T. Shirasaka et al., COMPARATIVE-ANALYSIS OF ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITIES OF DIDEOXYNUCLEOSIDE ANALOGS IN RESTING AND ACTIVATED PERIPHERAL-BLOOD MONONUCLEAR-CELLS, Antimicrobial agents and chemotherapy, 39(11), 1995, pp. 2555-2559
We determined the anti-human immunodeficiency virus type 1 (anti-HIV-1
) activities of various dideoxynucleoside analogs by using phytohemagg
lutinin-activated peripheral blood mononuclear cells (PHA-PBMs) and re
sting PBMs (R-PBMs) as target cells. The comparative order of anti-HIV
-1 activity in PHA-PBMs was azidothymidine (AZT) > dideoxycytidine (dd
C) > dideoxythymidinene (d4T) > dideoxyinosine (ddI) and 9-(2-phosphon
ylmethoxyethyl)adenine (PMEA) > 2'-beta-fluoro-dideoxyadenosine (F-ara
-ddA), while that in R-PBMs was ddC > ddI, PMEA, and F-ara-ddA, >> AZT
and d4T. A pronucleotide, bis-(S-acetylthioethanol)phosphotriester-dd
AMP, which bypasses the anabolic monophosphorylation step for the intr
acellular delivery of ddAMP, was highly active both in PHA-PBMs and R-
PBMs. These data may have basic and clinical relevance in the design o
f anti-HIV chemotherapy, particularly combination chemotherapy with di
deoxynocleosides, and in the development of active pronucleotides.